Novel Stochastic Sensors Based on Phthalocyanine Complexes for the Detection of C-NP, IL-6, and CRP in Cardiovascular

Ruxandra-Maria Ilie-Mihai1, Raluca-Ioana Stefan-van Staden1

  • 1Laboratory of Electrochemistry and PATLAB, National Institute of Research for Electrochemistry and Condensed Matter, 202 Splaiul Independentei Str., 060021 Bucharest, Romania.

Life (Basel, Switzerland)
|February 27, 2026
PubMed

Insights

Highly sensitive stochastic sensors detect cardiovascular disease biomarkers C-reactive protein, interleukin 6, and C-type natriuretic peptide at ultralow concentrations in whole blood, enabling real-time analysis.

Area of Science:

  • Biomarker Detection
  • Nanomaterials Science
  • Cardiovascular Diagnostics

Background:

  • Cardiovascular disease severity correlates with C-reactive protein, interleukin 6, and C-type natriuretic peptide levels.
  • Accurate and sensitive detection of these biomarkers is crucial for timely diagnosis and management.
  • Existing methods may lack the sensitivity required for ultralow level detection in real-time.

Purpose of the Study:

  • To develop and validate novel stochastic sensors for the simultaneous detection of key cardiovascular disease biomarkers.
  • To achieve ultralow detection limits and broad linear ranges for enhanced diagnostic capabilities.
  • To assess the reliability and statistical significance of the sensor performance compared to established methods like ELISA.

Main Methods:

  • Fabrication of stochastic sensors using carbon paste matrices functionalized with silver nanoparticles (AgNPs).
  • Immobilization of different phthalocyanines onto AgNP-decorated matrices for specific biomarker recognition.
  • Analysis of whole blood samples from cardiovascular patients using the developed sensors and comparison with ELISA results.

Main Results:

  • The developed stochastic sensors demonstrated exceptionally low detection limits (1 × 10-21 g mL-1).
  • Broad linear concentration ranges (1 × 10-21 to 1 × 10-6 g mL-1) were achieved, suitable for various clinical scenarios.
  • Statistical analysis (Student t-test) confirmed no significant difference between sensor results and ELISA at a 99% confidence level.

Conclusions:

  • The novel stochastic sensors offer high sensitivity and reliability for detecting cardiovascular disease biomarkers in whole blood.
  • These sensors represent a promising advancement for real-time, ultralow level biomarker analysis in cardiovascular diagnostics.
  • The validated performance suggests potential for clinical application in cardiovascular disease screening and monitoring.